BRIEF published on 01/26/2026 at 09:56, 4 months 22 days ago Goldman Sachs crosses thresholds in Nanobiotix Voting Rights Goldman Sachs Crossing Thresholds NANOBIOTIX Off-market Acquisition
BRIEF published on 01/13/2026 at 22:20, 5 months 4 days ago Nanobiotix's monthly information on shares and voting rights Voting Rights Euronext Actions Nasdaq NANOBIOTIX
BRIEF published on 01/13/2026 at 22:20, 5 months 4 days ago Nanobiotix Reports Voting Rights and Share Capital Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE published on 01/13/2026 at 22:15, 5 months 4 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. Listed on Euronext Paris and Nasdaq. Pioneering biotech company with disruptive therapeutic approaches Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 12/15/2025 at 08:35, 6 months 2 days ago NANOBIOTIX to Enter CAC Mid 60 and SBF 120 Indices Euronext Paris Biotechnology SBF 120 NANOBIOTIX CAC Mid 60
BRIEF published on 12/15/2025 at 08:35, 6 months 2 days ago NANOBIOTIX joins the CAC Mid 60 and SBF 120 indices Investors Biotechnology NANOBIOTIX CAC Mid 60 Stock Market Indices
PRESS RELEASE published on 12/15/2025 at 08:30, 6 months 2 days ago NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris Nanobiotix to join CAC Mid 60 and SBF 120 indices on Euronext Paris, enhancing visibility and market presence. CEO Laurent Levy expresses confidence in company's long-term strategy Euronext Paris SBF 120 NANOBIOTIX Index Inclusion CAC Mid 60
BRIEF published on 12/05/2025 at 15:54, 6 months 12 days ago Goldman Sachs reduces its stake in NANOBIOTIX Voting Rights Goldman Sachs Crossing Thresholds Transfer Of Shares NANOBIOTIX
BRIEF published on 11/17/2025 at 15:31, 7 months ago The Goldman Sachs Group reduces its stake in NANOBIOTIX Actions Goldman Sachs NANOBIOTIX 5% Threshold Title Loan
BRIEF published on 11/13/2025 at 22:20, 7 months 4 days ago Nanobiotix Advances Curadigm Nanoprimer Platform for Improved Drug Delivery Nanotechnology Drug Delivery NANOBIOTIX Curadigm Platform Therapeutic Vaccines
Published on 06/18/2026 at 00:00, 24 minutes ago LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 54 minutes ago Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 1 hour 34 minutes ago International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 1 hour 54 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 7 hours 29 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/17/2026 at 21:40, 2 hours 43 minutes ago Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 5 hours 14 minutes ago Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 5 hours 44 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 5 hours 47 minutes ago BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares
Published on 06/17/2026 at 18:23, 6 hours 1 minute ago EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG
Published on 06/17/2026 at 17:40, 6 hours 44 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 15 hours 39 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 12 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 1 hour ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 5 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
